Vaccine PracticeSPECIVACNCT03403114
Vaccine Attitudes and Practices of Hospital Specialists
An observational study of Vaccine Practice, run by Assistance Publique - Hôpitaux de Paris at 14 sites in France.
Trial summary
This study aims to evaluate the perceptions and knowledge of hospital specialists regarding vaccine recommendations targeting their patients, to study their behavior with respect to these recommendations and to quantify their vaccine hesitancy. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Vaccine Practice
- What is being tested?
- Questionnaire
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 1,851 participants
- Where
- 14 sitesFrance
- Study dates
- 1 Feb 2018to 4 Oct 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: * Physicians with a frequent activity of practice and advice vaccines, called "vaccinators" (most medical specialties): 100% of those meeting the inclusion criteria will be contacted for inclusion * Physicians "no or weak vaccinators" (anesthesiologists, surgeons, psychiatrists…): 30% of those meeting the inclusion criteria will be chosen by drawing lots
Who may be able to join
- To be a physician in one of the participating institutions
- Or to be a contract physician in participating institutions
Who cannot join
- Interns
- Attached practitioners
- Emergency physicians
Trial locations and contacts
14 sites in 1 country.
14 sites in 1 country
France14 sites
CRC Annecy
Annecy, 74370
CIC Besançon
Besançon, 25030
CIC Clermont-Ferrand
Clermont-Ferrand, 63003
CIC Dijon
Dijon, 21079
CIC Lille
Lille, 59045
CIC Limoges
Limoges, 87042
Service d'Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Edouard Herriot et Unité de recherche clinique ne Immunologie du centre hospitalier Lyon Sud
Lyon, 69437
CIC Montpellier
Montpellier, 34295
Service de maladies infectieuses Nancy
Nancy, 54511
Service de maladies infectieuses Nîmes
Nîmes, 30029
CIC Cochin Pasteur
Paris, Île-de-France Region, 75014
CIC Bichat
Paris, Île-de-France Region, 75877
CIC Rennes
Rennes, 35033
CIC Strasbourg
Strasbourg, 67000
About this study
This study aims to evaluate the perceptions and knowledge of hospital specialists regarding vaccine recommendations targeting their patients, to study their behavior with respect to these recommendations and to quantify their vaccine hesitancy.
- Conditions
- Vaccine Practice
- Being tested
- Questionnaire
- Keywords
- Vaccine hesitancy, Hospital specialists (HS), Vaccination survey
- Medical subject headings
- Vaccination Hesitancy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireBehavioural
a 15min questionnaire
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportions of Hospital Specialists (HS) with knowledge of vaccine recommendations targeting their patients
Measured: 15 minutes
Proportions of HS regularly recommending recommended vaccines to their patients
Measured: 15 minutes
Proportions of HS with doubts about recommended vaccines
Measured: 15 minutes
Secondary outcomes (5)
Link between perception of benefits and risks of vaccines, knowledge of vaccine-preventable diseases, trust in different sources of information and vaccine hesitancy will be measured by questionnaire (measure by multiple logistic regressions)
Measured: 15 minutes
Measure of attitudes and practices of HS vis-a-vis to vaccination and their specialty by questionnaire
number of HS vaccinator or not by specialty in connection with their attitudes and practices
Measured: 15 minutes
Percentages of HS feeling sufficiently trained or confident to explain to patients about vaccines
Measured: 15 minutes
Percentages of HS claiming to be vaccinated, by type of vaccine
Measured: 15 minutes
Percentages of HS children reported vaccinated by type of vaccine
Measured: 15 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jan 2018
- Study start1 Feb 2018
- Primary completion4 Oct 2019
- Study completion4 Oct 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Vaccine PracticeStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,851 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- Innovative clinical research network in vaccinology (I-REIVAC), Observatoire Régionale de la santé ORS-PACA
- Responsible party
- Sponsor
- Investigators
- Odile LAUNAY, Professor, Principal investigator, CIC 1417 Centre d'investigation cliniquePierre VERGER, MD, Study chair, ORS PACA UMR 912 SESSTIM
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03403114
- Sponsor's protocol ID
- NI16019
- Acronym
- SPECIVAC
- Status last verified
- Apr 2021
- First submitted
- 11 Dec 2017
- Last updated
- 19 Apr 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Vaccine Attitudes and Practices of Hospital Specialists
- ClinicalTrials.gov ID
- NCT03403114
- Acronym / sponsor ID
- SPECIVAC / NI16019
- Conditions
- Vaccine Practice
- Keywords
- Vaccine hesitancy, Hospital specialists (HS), Vaccination survey
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,851 participants (actual)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Collaborators
- Innovative clinical research network in vaccinology (I-REIVAC), Observatoire Régionale de la santé ORS-PACA
- Study start
- 1 Feb 2018 (actual)
- Primary completion
- 4 Oct 2019 (actual)
- Study completion
- 4 Oct 2019 (actual)
- First posted
- 18 Jan 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the perceptions and knowledge of hospital specialists regarding vaccine recommendations targeting their patients, to study their behavior with respect to these recommendations and to quantify their vaccine hesitancy.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- * Physicians with a frequent activity of practice and advice vaccines, called "vaccinators" (most medical specialties): 100% of those meeting the inclusion criteria will be contacted for inclusion * Physicians "no or weak vaccinators" (anesthesiologists, surgeons, psychiatrists…): 30% of those meeting the inclusion criteria will be chosen by drawing lots
Key inclusion criteria (2 listed)
- To be a physician in one of the participating institutions
- Or to be a contract physician in participating institutions
Key exclusion criteria (3 listed)
- Interns
- Attached practitioners
- Emergency physicians
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Questionnairea 15min questionnaire | Behavioural | – |
Primary outcome
Proportions of Hospital Specialists (HS) with knowledge of vaccine recommendations targeting their patients
Time frame: 15 minutes
Proportions of HS regularly recommending recommended vaccines to their patients
Time frame: 15 minutes
Proportions of HS with doubts about recommended vaccines
Time frame: 15 minutes
5 secondary outcomes
Link between perception of benefits and risks of vaccines, knowledge of vaccine-preventable diseases, trust in different sources of information and vaccine hesitancy will be measured by questionnaire (measure by multiple logistic regressions)
Time frame: 15 minutes
Measure of attitudes and practices of HS vis-a-vis to vaccination and their specialty by questionnaire
Time frame: 15 minutes
Percentages of HS feeling sufficiently trained or confident to explain to patients about vaccines
Time frame: 15 minutes
Percentages of HS claiming to be vaccinated, by type of vaccine
Time frame: 15 minutes
Percentages of HS children reported vaccinated by type of vaccine
Time frame: 15 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Apr 2021.
- Individual participant dataSharing planned: No
Related trials for Vaccine Practice
Recruiting
The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions
Human Papillomavirus (HPV), Papillomavirus Vaccines
Not yet recruiting
A Multifaceted Intervention on Reducing Immunization Errors
Vaccines, Vaccines Adverse Reaction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Odile LAUNAY, Professor principal investigator
CIC 1417 Centre d'investigation clinique
Pierre VERGER, MD study chair
ORS PACA UMR 912 SESSTIM
14 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vaccine Practice, run by Assistance Publique - Hôpitaux de Paris at 14 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 14 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportions of Hospital Specialists (HS) with knowledge of vaccine recommendations targeting their patients (time frame: 15 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2021; AzTrials last refreshed its copy on 7 Nov 2026.